Status:
COMPLETED
Cerebellar Neuromodulation to Enhance Fear Extinction and Predict Response to Exposure Therapy
Lead Sponsor:
Laureate Institute for Brain Research, Inc.
Conditions:
Anxiety Disorders
Social Phobia
Eligibility:
All Genders
18-70 years
Phase:
NA
Brief Summary
Emerging neuroimaging studies have shown that the cerebellum contributes to different aspects of timing, prediction, learning, and extinction of conditioned responses to aversive stimuli, factors that...
Detailed Description
Participants in this study will undergo an assessment for past history and present symptoms of mood, anxiety, trauma, substance abuse, and eating disorders. Safety screening for functional MRI (fMRI) ...
Eligibility Criteria
Inclusion
- Generalize Anxiety or Social Phobia with an OASIS score =\>8
Exclusion
- Safety concerns related to undergoing an fMRI scan or tDCS, such as metal in the head, history of unprovoked seizures in self or a first-degree family member, medications that reduce seizure threshold, pregnant or planning to become pregnant.
- History of Post Traumatic Stress Disorder, Obsessive Compulsive Disorder, Panic Disorder, Current Major Depressive Illness, Substance Abuse in the past 1-year, or any thought disorder such as schizophrenia or bipolar disorder.
Key Trial Info
Start Date :
August 1 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 31 2019
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT03275337
Start Date
August 1 2017
End Date
December 31 2019
Last Update
September 1 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Laureate Institute for Brain Research
Tulsa, Oklahoma, United States, 74011